摘要
血清癌胚抗原是最早用于肺癌诊断及预后评估的肿瘤标志物，尤其是在非小细胞肺癌的早期诊断、预后及疗效评估中尤为重要，但由于其敏感性较低，故目前越来越多研究倾向于联合其他肿瘤指标以提高其敏感性。本文结合近期相关文献，就癌胚抗原与非小细胞肺癌的关系作一综述。
Carcinoembryonic antigen （CEA） is the tumor biomarker, firstly used in the diagnosis and evaluation of prognosis for lung cancer,especially for non-small cell lung cancer （NSCLC）. Due to its low sensitivity, lots of studies tend to combine CEA and the other tumor markers to improve its validity. The purpose of the present study is to review the relationship between CEA and NSCLC.
出处
《国际呼吸杂志》
2012年第15期1180-1183,共4页
International Journal of Respiration
关键词
癌胚抗原
非小细胞肺癌
Carcinoembryonic antigen
Non-small cell lung cancer
